Strategies to Address the Long-Term Financial Burden of Cancer in Survivors

TON - May 2018, Vol 11, No 2 - Survivorship, Financial/Insurance Information
Meg Barbor, MPH
Strategies to Address the Long-Term Financial Burden of Cancer in Survivors By Meg Barbor, MPH

Because of the growing prevalence of cancer survivorship, the financial burden of cancer is becoming increasingly overwhelming for patients not only immediately after a cancer diagnosis, but often many years after treatment, according to K. Robin Yabroff, PhD, MBA, Strategic Director, Economic Burden of Cancer, American Cancer Society.

Cancer survivors often experience lasting effects of their disease or treatment. Compared with individuals without a history of cancer, survivors face an increased risk for new cancers and chronic conditions, devastating healthcare expenditures, work limitations and loss of health insurance, and foregone or delayed care because of insurmountable costs, she told the audience at the 2018 Cancer Survivorship Symposium.

US Health Insurance Trends

Employers are increasingly offering high-deductible health insurance plans, adding to the out-of-pocket burden for patients. Among the insured, cost-sharing has also increased through coinsurance and copayments. With a common 30% to 40% coinsurance rate for specialty cancer drugs, a drug costing $100,000 would cost a patient $30,000 to $40,000 out of pocket annually. “And that’s not uncommon,” she noted.

at a glance

    
  • The growing population of cancer survivors is leading to increasing financial burden
  • 
  • Commercially insured patients often face tens of thousands of dollars in out-of-pocket costs for specialty cancer drugs
  • 
  • Cancer survivors under age 64 years face greater financial hardship because they lack Medicare coverage
  • Increased financial burden is linked to poorer treatment outcomes
  • It’s important to consider multiple levels in understanding financial hardship and opportunities for intervention

The number of uninsured Americans has also recently increased, and according to Dr Yabroff, that number may skyrocket even higher in the near future. Changes in treatment patterns have led to more patients getting treatment for longer periods of time, often with combination instead of single-­agent treatments, and as a result, increasing the unit cost of treatment.

The Reality of Bankruptcy

A 2013 study by Ramsey and colleagues linked cancer registry data to bankruptcy claim files and showed that in every single year between 1995 and 2009, the risk of bankruptcy was higher for survivors compared to those without a history of cancer.

A 2016 follow-up study by the same authors restricted the analysis to survivors who filed for bankruptcy compared with those who did not and showed significantly increased mortality risk among those who filed for bankruptcy. The hypothesized mechanisms for this effect include lower quality of life and lower overall well-being, increased stress, and decreased treatment adherence or access to care. “This finding was very compelling,” she said.

The Financial Hardship Framework

The framework for describing financial hardship includes 3 distinct but overlapping components, according to Dr Yabroff. These components include material conditions (ie, medical debt, high out-of-pocket costs); psychological response (ie, stress and distress about high costs); and coping behaviors (ie, delaying filling a prescription, taking less medication, or skipping doses).

A 2016 analysis using the 2011 Medical Expenditure Panel Survey: Experiences with Cancer Survivorship Supplement estimated that 7% of cancer survivors had to borrow money or go into debt and 12% were unable to cover their share of medical care costs. Overall, 20% of cancer survivors had some type of material financial hardship and 23% experienced some type of psychological financial hardship. A stratified analysis of the data revealed that patients aged ≤64 years faced more financial hardship, because of ineligibility for Medicare coverage. Approximately 40% of survivors aged 18 to 64 years had at least some form of financial hardship, compared with 20% of those aged ≥65 years.

For material financial hardship specifically, only about 12% of patients aged ≥65 years reported some hardship, whereas approximately 50% among the uninsured and publicly insured people in the younger cohort reported material financial hardship. Rates were lower for those with private insurance, but almost 25% of patients in this group still reported some form of material financial hardship. Findings were similar for psychological financial hardship when stratified by age-group and type of insurance.

“I want to emphasize the types of things survivors are spending mon­ey on,” Dr Yabroff said. “It’s not just medical care.” A 2012 LiveSTRONG survey on out-of-pocket spending among cancer survivors who reported borrowing money or having medical debt revealed that 60% cited the high cost of transportation, although lodging, child care, and home or respite care were also major concerns.

Patient characteristics associated with a high risk for financial hardship include younger age, minority race or ethnicity, lower household income, being unemployed, and being uninsured or underinsured.

“The populations that have the highest risk of financial hardship are the same populations we’ve seen have much poorer outcomes for cancer,” she said. “So there is a risk that with increasing financial hardship, we’ll see greater health disparities in the future.”

Strategies to Address Financial Hardship

“When we’re thinking about different strategies to address the financial hardship of cancer, interventions need to happen at multiple levels,” Dr Yabroff asserted.

Financial navigators can be invaluable at the patient level. At the provider level, more enhanced discussions about the expected costs and benefits of treatment can prepare patients for what’s ahead. At the organizational level, one strategy would be the implementation of a value-based insurance design.

State policy decisions can affect Medicaid eligibility expansion, and in the current national policy environment, influencers can work on closing the Medicare Part D donut hole.

“Many cancer survivors blow through that donut hole very quickly,” she said. “It’s important to consider multiple levels in understanding financial hardship and opportunities for intervention.”

Related Items
Fear of Recurrence in Cancer Survivors Different from Depression or Distress
Meg Barbor, MPH
TON - May 2018, Vol 11, No 2 published on May 15, 2018 in Survivorship, Financial/Insurance Information
“Superhero” Navigators Convene at the 8th Annual Navigation & Survivorship Conference
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 published on March 9, 2018 in Conference Correspondent, AONN+ News
The Challenges of Oral Cancer Drugs Use and Side-Effects Management
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 published on March 9, 2018 in Side-Effects Management, Drug Updates & News, ESMO
Silent Patients Find Their Voices Through an Advocate’s Journey
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 published on March 9, 2018 in Patient Advocacy, Conference Correspondent, ESMO
Measuring Financial Well-Being in Cancer Survivorship
Meg Barbor, MPH
TON - March 2018, Vol 11, No 1 published on March 9, 2018 in Conference Correspondent, Survivorship
Supportive Care Updates from ASCO 2017 Highlighted at New Orleans Summer Cancer Meeting
Meg Barbor, MPH
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Supportive Care
Practice-Changing Results with Abiraterone plus Prednisone in Metastatic Hormone-Naïve Prostate Cancer
Meg Barbor, MPH
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Prostate Cancer
The Role of Integrative and Alternative Medicine in Cancer Care
Meg Barbor, MPH
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Alternative Medicine
Addressing Usability Concerns in Oncology Electronic Health Records
Meg Barbor, MPH
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Best Practices
New Drug Therapies for Relapsed or Refractory Multiple Myeloma
Meg Barbor, MPH
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Multiple Myeloma
Last modified: June 13, 2018